Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 6.3197.66-47.11-18.43-26.72

What is the latest EBIT Growth ratio of BLISS GVS PHARMA ?

The latest EBIT Growth ratio of BLISS GVS PHARMA is 6.31 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar20246.31
Mar202397.66
Mar2022-47.11
Mar2021-18.43
Mar2020-26.72

How is EBIT Growth of BLISS GVS PHARMA Trending?

Years EBIT Growth % Change
Mar2024 6.31
-93.54
Mar2023 97.66
Positive
Mar2022 -47.11
Negative
Mar2021 -18.43
Negative
Mar2020 -26.72 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EBIT Growth ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,254.3 Cr -5.8% -1.7% 5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,126.0 Cr 1.4% 4.1% 18.7% Stock Analytics
DIVIS LABORATORIES ₹161,568.0 Cr -2.1% 4.2% 59.1% Stock Analytics
CIPLA ₹125,156.0 Cr -0.1% 5% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,176.0 Cr -0.3% 3% 23.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,716.1 Cr -1.5% 1.7% -5.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-5.8%

-1.7%

5.1%

SENSEX

0.2%

2.9%

8.7%


You may also like the below Video Courses